Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gaush Meditech Ltd. ( (HK:2407) ) has issued an update.
Gaush Meditech Ltd has announced a change in the name of its principal share registrar and transfer office in the Cayman Islands, effective April 17, 2026. The registrar has been renamed from Harneys Fiduciary (Cayman) Limited to Ascentium (Cayman) Limited, while the office address and core corporate structure remain unchanged.
The move represents an administrative adjustment to the company’s back-office and shareholder services arrangements rather than a shift in business strategy or operations. With the board composition and registered office location intact, the change is expected to have minimal direct impact on day-to-day activities but may affect how shareholders interface with the company’s share registration services.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. It operates in the medical technology sector, although this announcement focuses on corporate administrative arrangements rather than its products, services, or specific market focus. The board comprises executive, non-executive and independent non-executive directors based in Hong Kong and abroad.
Average Trading Volume: 62,733
Technical Sentiment Signal: Sell
Current Market Cap: HK$780.8M
See more insights into 2407 stock on TipRanks’ Stock Analysis page.